Baisong Mei
CIK: 0001938499
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)2 (100.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About Mei Baisong
Mei Baisong (SEC CIK 0001938499) files insider reports with the SEC as Chief Medical Officer of CITY THERAPEUTICS, INC. (CTY) and EVP, CHIEF MEDICAL OFFICER of Editas Medicine, Inc. (EDIT).
Signal8 holds 3 ownership filings by Mei Baisong (1 Form 3, 2 Form 4), filed between Sep 6, 2024 and Oct 15, 2026. Those filings report 2 transactions, from Sep 4, 2024 to Dec 3, 2024. Signal8's Form 4 history starts in Sep 2024.
The business address on Mei Baisong's filings is in CAMBRIDGE, MA.
Recent filings by Mei Baisong
Other insiders filing for CITY THERAPEUTICS, INC. (CTY)
- ARCH Venture Partners XII, LLC, 10% Owner
- NELSEN ROBERT, Director
- MARAGANORE JOHN, Director
- Nochur Sara, Director
- ORTH ANDREW C., President & CEO
- Philip Ron M, Director